CytomX Therapeutics Stock (NASDAQ: CTMX) stock price, news, charts, stock research, profile.
Open | $2.200 |
Close | - |
Volume / Avg. | 2.776M / 881.142K |
Day Range | 2.180 - 2.300 |
52 Wk Range | 1.040 - 2.855 |
Market Cap | $148.988M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | 1.94% |
Days to Cover | 6.47 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CytomX Therapeutics (NASDAQ: CTMX) through any online brokerage.
Other companies in CytomX Therapeutics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Molecular Partners (NASDAQ:MOLN), Vincerx Pharma (NASDAQ:VINC), Galectin Therapeutics (NASDAQ:GALT) and Sangamo Therapeutics (NASDAQ:SGMO).
The latest price target for CytomX Therapeutics (NASDAQ: CTMX) was reported by BMO Capital on Tuesday, March 12, 2024. The analyst firm set a price target for 3.25 expecting CTMX to rise to within 12 months (a possible 43.81% upside). 5 analyst firms have reported ratings in the last year.
The stock price for CytomX Therapeutics (NASDAQ: CTMX) is $2.26 last updated Today at March 28, 2024 at 9:15 AM EDT.
There are no upcoming dividends for CytomX Therapeutics.
CytomX Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for CytomX Therapeutics.
CytomX Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.